Odalasvir
Showing 1 - 15 of 15
Hepatitis C Trial in Worldwide (No Treatment)
Terminated
- Hepatitis C
- No Treatment
-
Vancouver, British Columbia, Canada
- +10 more
May 12, 2020
Hepatitis C, Chronic Trial in Japan (AL-335, Odalasvir (ODV), Simeprevir (SMV))
Renal Insufficiency Trial in Orlando, Knoxville (Odalasvir)
Completed
- Renal Insufficiency
- Odalasvir
-
Orlando, Florida
- +1 more
May 14, 2018
Healthy Trial in Surrey (Odalasvir (ODV), AL-335, Placebo)
Completed
- Healthy
- Odalasvir (ODV)
- +2 more
-
Surrey, United Kingdom(unnamed)
Mar 28, 2018
Healthy Trial in Tempe (Simeprevir 75 mg, Odalasvir 25 mg, Odalasvir 12.5 mg)
Terminated
- Healthy
- Simeprevir 75 mg
- +6 more
-
Tempe, ArizonaCelerion
Dec 21, 2017
Healthy Trial in Tempe (ODV Placebo (Matching 25 mg ODV), ODV Placebo (Matching 200 mg ODV), ODV Placebo (Matching 125 mg ODV))
Completed
- Healthy
- ODV Placebo (Matching 25 mg ODV)
- +12 more
-
Tempe, ArizonaCelerion
Nov 10, 2017
Hepatic Impairment Trial (AL-335 800 mg, ODV 25 mg, SMV 75 mg)
Withdrawn
- Hepatic Impairment
- AL-335 800 mg
- +2 more
- (no location specified)
Oct 10, 2017
Healthy Trial in Tempe (Dabigatran etexilate mesylate, Odalasvir (ODV), Simeprevir (SMV))
Completed
- Healthy
- Dabigatran etexilate mesylate
- +2 more
-
Tempe, Arizona(unnamed)
Jun 7, 2017
Healthy Trial in Tempe (Odalasvir 100 mg, Placebo, Odalasvir 500 mg)
Completed
- Healthy
- Odalasvir 100 mg
- +3 more
-
Tempe, Arizona(unnamed)
Apr 7, 2017
Healthy Trial in Overland Park (Drospirenone/ethinylestradiol, AL-335, Odalasvir (ODV))
Completed
- Healthy
- Drospirenone/ethinylestradiol
- +3 more
-
Overland Park, Kansas(unnamed)
Jan 20, 2017